ArticleWorld journal of surgical oncology2026
MiR-5100 promotes the malignant phenotype of triple-negative breast cancer cells by targeting SMAD4 and predicts poor prognosis.
Yaxi Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.